The Center for Implementation Science and Translation Research at the National Heart, Lung and Blood Institute (NHLBI) convened experts with backgrounds in de-implementation research and other relevant clinical and public health areas, including behavioral economics, ethics and culture, and implementation research, to explore, discuss, and garner information on high priority areas in de-implementation research.
Research Meeting Summaries
Filter Research Meeting Summaries
The National Heart, Lung, and Blood Institute (NHLBI) and the American Association for Thoracic Surgery (AATS) co-sponsored a workshop to identify clinical research priorities in lung transplant research, with a particular focus on the time from recipient selection to one year post-transplant.
The workshop included presentations in the areas of recipient selection, donor management, perioperative issues, and primary grant dysfunction, as well as discussion of the research gaps and priorities for lung transplantation research.
The National Heart, Lung, and Blood Institute (NHLBI) convened several experts from a broad range of biomedical, behavioral, environmental, and social science backgrounds to explore community-engaged implementation research strategies for reducing cardiovascular disparities. Findings from this workshop will help inform NHLBI Strategic Vision Implementation Plan for health disparities implementation research and will have significant impact when scaled up across high burden communities.
The National Heart, Lung, and Blood Institute (NHLBI) convened a working group (WG) on the “Role of Lipid Droplets (LDs) in Obesity and Metabolic Syndrome Related Cardiovascular Diseases (CVD),” in Bethesda, Maryland. The objectives of the working group were to evaluate the state of the field in LDs, identify the gap areas, and recommend research opportunities to investigate the roles of LDs in the pathogenesis of obesity- and metabolic syndrome-related CVD.
NHLBI Workshop on Implementation Research to Address Gaps in International Blood Availability and Transfusion Safety in Low and Middle Income Countries (LMICs)
The National Heart, Lung, and Blood Institute (NHLBI) convened a working group (WG) on Future Research Directions on Lipoprotein(a) and Cardiovascular Disease in Bethesda, Maryland to evaluate the state of the art of Lipoprotein(a) (Lp(a)) research and the roles of Lp(a) in cardiovascular disease (CVD), to identify research gaps and barriers, and to recommend future research opportunities in Lp(a) research.
The National Heart, Lung, and Blood Institute (NHLBI) convened a working group of multidisciplinary researchers on June 10, 2016, in Bethesda, MD to share current scientific knowledge regarding the role of microbiota in blood pressure regulation, and to explore and identify scientific gaps and challenges.
The working group is responsive to NHLBI Strategic Plan Objectives 1, 2, 3, and 4.